Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties.

CONCLUSIONS NP might be used as an adjuvant therapy for ER+ BC patients with TAM resistance. PMID: 31760402 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research